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ABSTRACT 
Asthma is a common childhood disease and several risk factors have been identified, however 
the impact of genes and environment is not fully understood. The aim of the Swedish Twin 
study On Prediction and Prevention of Asthma (STOPPA) is to identify environmental (birth 
characteristics and early life) and genetic (including epigenetic) factors as determinants for 
asthmatic disease. 
Based on the Child and Adolescent Twin Study in Sweden (parental interview at 9 or 12 
years, N~23,900) and an asthma and/or wheezing algorithm, we identified a sample of 
monozygotic (MZ) and dizygotic (DZ) same-sexed twin pairs. The twin pairs were identified 
as asthma concordant (ACC), asthma discordant (ADC) and healthy concordant (HCC). A 
sample of 9- to 14-year-old twins and their parents were invited to participate in a clinical 
examination. Background characteristics were collected in questionnaires and obtained from 
the National Health Registers. A clinical examination was performed to test lung function and 
capacity (spirometry with reversibility test and exhaled nitric oxide) and collect blood 
(serology and DNA), urine (metabolites), feces (microbiota) and saliva (cortisol). 
In total, 376 twin pairs (752 individual twins) completed the study, response rate 52%. All 
participating twins answered the questionnaire and >90% participated in lung function testing, 
blood and saliva sampling.  
This article describes the design, recruitment, data collection, measures, background 
characteristics as well as ongoing and planned analyses in STOPPA. Potential gains of the 
study include the identification of biomarkers, the emergence of candidates for drug 
development and new leads for prevention of asthma and allergic disease. 
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INTRODUCTION 
Asthma is an inflammatory and obstructive disease of the airways, with increasing prevalence 
around the world (Asher, Montefort et al. 2006). Observed marked variation in prevalence 
between genetically similar populations strongly implies that a substantial proportion is 
attributable to environmental aspects (von Mutius, Martinez et al. 1994). Heritability 
estimates specific to populations and given environments have indicated genetic factors to be 
responsible for 60-80% of liability to asthma and respiratory measures, and the remaining 20-
40% due to environmental influence (Lichtenstein and Svartengren 1997; Los, Postmus et al. 
2001; Wu, Boezen et al. 2010). There has been an upsurge in observational birth cohort 
studies and randomised controlled trials such as BAMSE in Sweden (Wickman, Kull et al. 
2002), the German Multicentre Allergy Study (Lau, Nickel et al. 2002), PIAMA Holland 
(Wijga, Smit et al. 2001), the Childhood Asthma Prevention Study in Sydney (Mihrshahi, 
Peat et al. 2001) and the Manchester cohort in UK (Custovic and Simpson 2004), along with 
large consortia to better understand the impact of environmental risk factors of asthma and 
allergic disease. Several risk factors have been identified, but there are still controversies over 
many exposures.  
We have recently shown that there is an association between birth weight and subsequent 
asthma (Ortqvist, Lundholm et al. 2009) and eczema (Lundholm, Ortqvist et al. 2010) in 
twins. The observed association was independent of gestational age, familial environment and 
genetic factors, implying that altered foetal growth affects early metabolic, immunologic or 
physiologic mechanisms in utero, leading to subsequent disease. The foetal origins hypothesis 
(Barker 1995) states that foetal malnutrition in utero may result in disproportionate neonatal 
growth that may lead to catch-up growth, causing an increased risk of subsequent obesity 
(Stettler, Zemel et al. 2002).  Both asthma and obesity seem to have their commencement in 
early childhood (Snethen, Hewitt et al. 2007; Drever, Saade et al. 2010). It is possible that 
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other unshared environmental exposures such as breast feeding and diet, physical activity and 
body mass index (BMI) may predispose individuals to both these conditions and may explain 
how they are associated. However, just as asthma, most exposures are influenced by genetic 
effects, and therefore genetic confounding cannot be excluded. This is one area where twin 
studies may provide an alternative and very powerful approach. 
There is also accumulating epidemiologic (Braun-Fahrlander, Gassner et al. 1999; Ball, 
Castro-Rodriguez et al. 2000; Karmaus and Botezan 2002), clinical (Matricardi 2002), and 
experimental (Blaser, Chen et al. 2008) data supporting the “hygiene hypothesis” (Strachan 
1989), and it would not be far-fetched to postulate that perturbations in the gastrointestinal 
microflora could disrupt the normal mechanisms of immunological tolerance in the mucosa 
(Noverr and Huffnagle 2005), leading to an increased risk of several childhood-onset allergic 
disorders (Sjogren, Jenmalm et al. 2009). The quantification of eicosanoid metabolites in 
human urine has been demonstrated to provide insight into the inflammatory and oxidative 
stress status of the individual, which might play a role in the pathobiology and severity of 
asthma (Balgoma, Larsson et al. 2013). There is also an association between early measures 
of stress and asthma (Fang, Hoglund et al. 2011) and although findings are inconsistent (Vink, 
Boezen et al. 2013), measures of stress in saliva cortisol may affect allergic symptoms 
(Stenius, Borres et al. 2011).Thus, if the effects are causal it is expected that the associations 
between objective measures such as spirometry, serology, gut microflora, urinary metabolites 
as well as saliva cortisol and parent-reported asthma remain also within twin pairs.  
Twin siblings share genes (half if DZ and all if MZ), some intrauterine exposures, maternal 
factors and early environment. These renowned differences in genetic similarity, together with 
the assumption that twins within a pair are exposed equally to environments, irrespective of 
zygosity, create the foundation for the twin design, exploring the effects of genetic and 
environmental variance on a phenotype. Differences between MZ twins may either be an 
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effect of purely environmental factors or genetic variation that arises after fragmentation of 
the fertilized embryo, and MZ twin pairs discordant for asthma are especially powerful to 
study the effect of early environment such as breast feeding and diet, BMI, physical activity 
and personality on disease development. It has been demonstrated that genetic variation can 
occur after birth, either through somatic mutations or epigenetic changes (Wong, Caspi et al. 
2010; Martino, Loke et al. 2013). It has also been hypothesised that epigenetics may be a 
molecular link between environmental factors and phenotypic changes (Lund, Kongerud et al. 
2007; Bruder, Piotrowski et al. 2008; Prescott and Clifton 2009; Zhang, Li et al. 2012). A few 
epigenetic mechanisms have been proposed to be involved in the development of asthma 
(Hollingsworth, Maruoka et al. 2008; Liu, Ballaney et al. 2008). However, more direct 
mechanistic links to asthma pathogenesis needs to be determined.  
The overarching purpose of this research program is to identify environmental (birth 
characteristics and early life), genetic and epigenetic factors as determinants for asthmatic 
disease. We will use the powerful approach of questionnaires and objective measures based 
on clinical examinations in discordant and concordant MZ and DZ twins.  
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MATERIAL and METHODS 
Study design and population 
In 2004, the Swedish Twin Registry initiated the Child and Adolescent Twin Study in Sweden 
(CATSS) including all twins born from July 1992 onwards (N~23,900 twins in March 2014) 
whose parents answered a telephone interview on birth characteristics, zygosity, parental 
background factors as well as outcomes such as asthma and wheeze at 9 or 12 years of age 
(Lichtenstein, Sullivan et al. 2006; Anckarsater, Lundstrom et al. 2011). The questions on 
zygosity have been validated with DNA markers in previous studies and proved correct in 
95% (Lichtenstein, De Faire et al. 2002). 
Based on the CATSS interview ascertainment, the Swedish Twin study On Prediction and 
Prevention of Asthma (STOPPA) was initiated in May 2011. Validated questions on asthma 
ever (yes/no) and wheezing (current or after three years of age/no) from the International 
Study of Asthma and Allergies in Childhood, ISAAC (Asher, Keil et al. 1995) were used to 
create an algorithm to identify twins discordant and concordant for asthma, Figure 1. Three 
groups of monozygotic (MZ) and dizygotic (DZ) same-sexed twin pairs were identified; 1) 
both twins with asthma or wheezing (asthma concordant - ACC), 2) one twin with asthma or 
wheezing and the other without (asthma discordant - ADC), and 3) none of the twins with 
asthma or wheezing (healthy concordant - HCC). 
Figure 1 about here 
From each group (ACC, ADC and HCC), 9-14 year old twin pairs and their parents were 
invited to participate in a clinical examination including questionnaires and objective 
measures. Twins already recruited to other CATSS substudies were excluded. Eligible twins 
were invited in rounds related to examination site and date, age groups and the purpose to 
obtain equal sizes of the sub-groups.The families were contacted through an invitation letter, 
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followed by a telephone call to inform about the study. A clinical examination including 
questionnaires and objective measures were performed at Karolinska Institutet (Stockholm), 
Queen Silvia Children’s Hospital (Göteborg), Linköping’s University hospital, 
Centralsjukhuset in Karlstad, Norrland’s University hospital (Umeå), Lund Children’s 
Hospital, Lomma Primary Health Care Centre and Centrallasarettet in Växjö. The protocol 
between the pilot and the full scale study were identical apart from minor revisions of the 
questionnaire and collection of urinary samples during the last year of the study. After a 
successful pilot study including 15 MZ twin pairs in Stockholm and Uppsala, the full scale 
study started in November 2011 and was finalised in June 2014.  
Questionnaires 
At the test centre, the parents were invited to answer a questionnaire divided into eight main 
themes; parental background, lifestyle and medical history along with questions on each 
twin’s life style, general health status, medical history, puberty and home environment. The 
questionnaire was designed to collect information on factors that may be associated with 
childhood asthma, allergies and comorbidities with previously validated questions (Asher, 
Keil et al. 1995; Wickman, Kull et al. 2002; Danell, Bergstrom et al. 2013; Ekstrom, 
Magnusson et al. 2014).  Questions on twin’s medical history included respiratory diagnoses 
in infancy, wheezing and asthma including doctor’s diagnosis, age at onset and frequency 
(Asher, Keil et al. 1995; Wickman, Kull et al. 2002; Danell, Bergstrom et al. 2013; Ekstrom, 
Magnusson et al. 2014). For life style, general health and home environment, established 
questionnaires were used (Almqvist, Adami et al. 2011; Anckarsater, Lundstrom et al. 2011).  
Each twin was invited to answer a questionnaire, which was divided into four themes; life 
style, medical history, puberty and stress. Questions on puberty were those in the Pubertal 
Development Scale developed and validated by Petersen et al (Petersen, Crockett et al. 1988). 
The Perceived Stress Scale was used for the pilot (Cohen, Postma et al. 2011) and replaced by 
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the  21 item questionnaire “Stress in Children” (SiC) which has been validated against Beck 
Youth Inventory scales and objective measures of stress (Osika, Friberg et al. 2007) in the full 
scale study.  
The Asthma Control Test (ACT), a trademark of QualityMetric Incorporated including five 
items on symptoms and medication during the last four weeks, was used for twins >12 years 
of age and the Childhood Asthma Control Test (C-ACT) answered by twins <12 years (four 
items) and parents (three items) with permission from GlaxoSmithKline (Nathan, Sorkness et 
al. 2004; Liu, Zeiger et al. 2010).  
The parental and twin questionnaires were slightly revised between the pilot phase and full 
scale study and a few questions on early life respiratory diagnoses and exposure to antibiotics, 
physical activity, pet exposure and stress were added or modified. A research nurse contacted 
and completed missing information for the majority of pilot participants in retrospect.   
Clinical examination 
Spirometry. Lung function tests to measure how an individual inhales or exhales volumes 
(litres) of air as a function of time (seconds), was carried out with SpiroStar (Pro version, 
Medikro, Kuopio, Finland) in the majority of study participants. Approximately 100 twins 
were tested using the Jaeger MasterScreen-IOS system (Carefusion Technologies, San Diego, 
California) at one of the test centers in Stockholm. The procedures was performed in 
accordance with American Thoracic Society/European Respiratory Society recommendations 
(Miller, Hankinson et al. 2005). Both systems were calibrated using a 3L syringe. A 
reversibility test was included when the procedure was repeated at least three times before and 
15 min after inhalation of terbutalin 0.5 mg.  
Fractional exhaled NO (FeNO). Levels of FeNO, a non-invasive marker of airway 
inflammation (Dweik, Boggs et al. 2011) were measured with a hand-held electrochemical 
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analyzer (NIOX Mino, Aerocrine, Solna, Sweden) with an expiration time of 10 seconds in 
the majority of study participants. Approximately 100 twins were tested with the CLD 88 
FeNO test analyser (Ecomedics, Duernten, Switzerland) at one of the test centers in 
Stockholm. Each subject performed the test at least twice; if there was >5% difference 
between the first two measurements a third attempt was performed.  
Biosamples 
Blood. At the test centers EDTA whole blood for analyses of DNA (4 ml), Complete Blood 
Count (CBC; 4ml) and plasma aliquots (from EDTA 10 ml) were collected, along with tubes 
of lithium heparin with gel for analyses of proteins and PAXgene Blood RNA Tube 
(PreAnalytiX GmbH, Hombrechtikon, Switzerland) for analyses of RNA.  
Gut microflora. To investigate differences in the twin’s gut microflora, fecal samples were 
taken at home and brought to the test center.  The fecal samples were collected in a container 
with screw cap and spoon (length 101 mm/ ø 16.5 mm), and the twins were asked to fill at 
least 2/3 of the container. The samples were frozen at home in -18°C in a pre-frozen cool 
transport container. The container with the samples was transported to the test center in 
Styrofoam casing to ensure that the samples remained frozen. 
Saliva. Samples of morning- and night saliva for analysis of cortisol levels, a marker of stress, 
were collected at home in a commercial Salivette tube containing a cotton wool swab. The 
swab was rotated in the mouth for at least 1 min and then inserted back into the tube and kept 
in +5°C before transportation to the test center. At the test center the cortisol samples were 
centrifuged and thereafter primarily stored at -20°C.  
Urinary metabolites. Urinary samples were collected at two time points at the test center; on 
arrival and before leaving the center. The subjects were asked to pass all urine directly into a 
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measuring container and the total volume at each collection was noted. The urine was 
thereafter transferred to five 8 mL test tubes with caps before primary storage at -20°C.    
All test tubes and material used to collect fecal samples, saliva and urinary samples were 
provided from SARSTEDT AG & Co, Nümbrecht, Germany. 
At the end of each data collection, all samples, except those that were analysed directly at the 
test site for the full scale study (CBC), were transported to and stored at Karolinska 
Institutet’s Biobank at -80°C, until analysed for its specific cause.   
National registers 
The universal use of the Personal Identity Number, a unique identifier for each resident in 
Sweden, enables unambiguous linkage between the registers held by the National Board of 
Health and Welfare and the Swedish Twin Registry. Information on pre- and perinatal factors 
such as birth weight, birth length, gestational age, head circumference and mode of delivery 
from the Medical Birth Register can be linked to each twin. Information on the twins’ asthma 
medications from the Swedish Prescribed Drug Register and diagnosis in the National Patient 
Register provides additional information on asthma status. We have recently shown that 
asthma medication is a suitable proxy for asthmatic disease in children in this age group 
(Ortqvist, Lundholm et al. 2013). 
Child- and school health records 
To investigate how growth over time affects the risk of subsequent asthma, consent to collect 
the twins’ child- and school health records was collected.  
Statistical analyses 
For future studies and dependent on the specific research question, the collected data from 
questionnaires, objective measures and samples will be analysed with twin design such as 
structural equation models (SEM) or through co-twin control analyses where discordant twin 
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pairs are thought of as matched case-control pairs. Twin pairs who are discordant for the 
outcome will be analysed with the non-affected co-twin as a matched control to the affected 
twin with the exposure being the individual background characteristic. The outcome-
concordant twins and healthy concordant twins will be used as control groups. Analyses will 
be weighted, in order to account for the difference in sampling fractions in the six sampling 
groups (MZ ACC, MZ ADC, MZ HCC, DZ ACC, DZ ADC and DZ HCC). 
Descriptive statistics on numbers of examined twins, collected information from questionnaire 
and clinical measures presented here was calculated by Stata statistical software, version 13.  
The authors assert that all procedures contributing to this work comply with the ethical 
standards of the relevant national and institutional committees on human experimentation and 
with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the 
regional ethical review board in Stockholm, Sweden. Consent  
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RESULTS 
In total, 6174 twins were eligible, 1448 contacted, 870 accepted participation and 752 came to 
the clinical examination, response rate 52%, Figure 2. During recruitment, we invited twin 
pairs to obtain six groups of fairly similar size and our aim was to recruit as many ADC as 
possible. Among those eligible, the proportion of HCC twin pairs (65%) was higher than 
ADC (22%) and ACC (13%), and the proportion of MZ twin pairs was lower in the ADC 
(27%) than the ACC group (55%). In the final study population 38% of the twin pairs were 
ADC (49% MZ), 31% ACC (61% MZ) and 31% HCC (55% MZ). Altogether, 410 twins (205 
twin pairs) were MZ (54%) and 342 (171 pairs) DZ.  
Figure 2 about here 
The proportion of males (53%) was slightly higher than females in the final study population, 
the majority of twins were born 1999-2000 (46%) or 2001-2002 (34%) and had their clinical 
examination in Stockholm (60%), Göteborg (19%) or Lund/Lomma (8%), Table 1. The 
distribution of males and females, year of birth and site for clinical examination for the 
separate MZ and DZ subgroups was similar to the total study population, except that the 
proportion of males was slightly lower in MZ ADC (47%), MZ HCC (45%) and DZ HCC 
(44%).   
Table 1 about here 
In the final sample, all twins and their parents answered the questionnaires, 100% of the twins 
participated in measures of height and weight and the majority of twins took part in lung 
function measures (spirometry 98%, FeNO 94%), blood sampling (>90%) and saliva (97%), 
Figure 3. Fecal samples were collected in 47% and urinary samples in 19%.  
Figure 3 about here 
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DISCUSSION  
This is the first twin study on asthma concordant, discordant and healthy concordant twin 
children examined with questionnaires and a thorough clinical examination. The study design 
has a powerful approach with invitation of a large sample of 9-14 year old Swedish MZ and 
DZ twins based on the total population. There are a few previous similar studies on adult 
populations and of smaller size (Lund, Kongerud et al. 2007; Wu, Boezen et al. 2010).  This 
article describes the design, recruitment, data collection, measures, background characteristics 
as well as ongoing and planned analyses in STOPPA. 
We collected questionnaires and objective data from lung functions tests and biological 
samples. Well validated ISAAC questions on asthma and allergy including queries on current 
asthma were incorporated into the questionnaires to update information from the CATSS 
questionnaire which defined the asthma dis- and concordant groups ACC, ADC and HCC. We 
also obtained information on asthma severity from the ACT survey, and additional phenotypic 
information will be obtained from lung functions tests and exhaled NO. In addition, we will 
have the possibility to link data to the national health registers (diagnoses and prescribed 
drugs) for further phenotypic information.  
Questionnaires were completed by both parents and twins at the clinical test center, which 
ensured a high response rate. The majority of children also participated in lung function tests 
and consented to biosamples being taken. We had the possibility to travel to several sites and 
thus ensure that twins throughout Sweden were examined in a standardized way using mostly 
identical equipment and a tight team of study nurses. There are also some inherent limitations 
in the study. Twins were examined throughout the year including during pollen seasons and 
autumn with higher risk of upper respiratory tract infections, which may have affected some 
of their responses. Also, although we aimed to invite all ADC and ACC twins, we had to 
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perform examinations related to site, date and age group and thus made a great effort to obtain 
equal sizes of the sub-groups and a response rate of >50%. 
MZ twins discordant for asthma have interested clinicians and researchers over the years. 
Following developments in biotechnology, with the new possibilities to perform systematic 
large-scale investigations of DNA sequencing, DNA modifications, RNA, metabolites, and 
proteins levels, the interest in using twins for molecular epidemiology has increased, the 
rationale being that identified molecular differences may reflect causal mechanisms involving 
environmental exposures and/or constitute a direct cause of the phenotypic difference. DZ 
twins also give additional information. Mutations occurring after the split of the initial intact 
embryo and epigenetic (DNA methylation, histone acetylation) differences have been put 
forward as promising candidate mechanisms.  
This article describes the design, recruitment, data collection, measures, background 
characteristics as well as ongoing and planned analyses in STOPPA. We will make 
comparisons on the effect of environmental factors on outcomes across discordant and 
concordant twin pairs and initiate novel analyses on genome-wide methylation in extracted 
DNA. Potential gains of the study include the identification of biomarkers, the emergence of 
candidates for drug development, translational modeling, and new leads for prevention of 
asthma and allergic disease. 
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